Literature DB >> 25998963

Perforin and granzymes: function, dysfunction and human pathology.

Ilia Voskoboinik, James C Whisstock, Joseph A Trapani.   

Abstract

A defining property of cytotoxic lymphocytes is their expression and regulated secretion of potent toxins, including the pore-forming protein perforin and serine protease granzymes. Until recently, mechanisms of pore formation and granzyme transfer into the target cell were poorly understood, but advances in structural and cellular biology have now begun to unravel how synergy between perforin and granzymes brings about target cell death. These and other advances are demonstrating the surprisingly broad pathophysiological roles of the perforin–granzyme pathway, and this has important implications for understanding immune homeostasis and for developing immunotherapies for cancer and other diseases. In particular, we are beginning to define and understand a range of human diseases that are associated with a failure to deliver active perforin to target cells. In this Review, we discuss the current understanding of the structural, cellular and clinical aspects of perforin and granzyme biology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25998963     DOI: 10.1038/nri3839

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  189 in total

Review 1.  Perforin: structure, function, and role in human immunopathology.

Authors:  Ilia Voskoboinik; Michelle A Dunstone; Katherine Baran; James C Whisstock; Joseph A Trapani
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Human perforin permeabilizing activity, but not binding to lipid membranes, is affected by pH.

Authors:  Tilen Praper; Mojca Podlesnik Besenicar; Helena Istinic; Zdravko Podlesek; Sunil S Metkar; Christopher J Froelich; Gregor Anderluh
Journal:  Mol Immunol       Date:  2010-06-26       Impact factor: 4.407

3.  An adaptable standard for protein export from the endoplasmic reticulum.

Authors:  R Luke Wiseman; Evan T Powers; Joel N Buxbaum; Jeffery W Kelly; William E Balch
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

4.  Calcium uptake via endocytosis with rapid release from acidifying endosomes.

Authors:  J V Gerasimenko; A V Tepikin; O H Petersen; O V Gerasimenko
Journal:  Curr Biol       Date:  1998-12-03       Impact factor: 10.834

5.  Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation.

Authors:  Sunil S Metkar; Baikun Wang; Miguel Aguilar-Santelises; Srikumar M Raja; Lars Uhlin-Hansen; Eckhard Podack; Joseph A Trapani; Christopher J Froelich
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

6.  A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin.

Authors:  Christina Trambas; Federico Gallo; Daniela Pende; Stefania Marcenaro; Lorenzo Moretta; Carmela De Fusco; Alessandra Santoro; Luigi Notarangelo; Maurizio Arico; Gillian M Griffiths
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

7.  Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication.

Authors:  R van Domselaar; S A H de Poot; E B M Remmerswaal; K W Lai; I J M ten Berge; N Bovenschen
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

8.  Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.

Authors:  Jedd D Wolchok; James P Allison; Dmitriy Zamarin; Rikke B Holmgaard; Sumit K Subudhi; Joon Seok Park; Mena Mansour; Peter Palese; Taha Merghoub
Journal:  Sci Transl Med       Date:  2014-03-05       Impact factor: 17.956

9.  Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11.

Authors:  Udo zur Stadt; Jan Rohr; Wenke Seifert; Florian Koch; Samantha Grieve; Julia Pagel; Julia Strauss; Brigitte Kasper; Gudrun Nürnberg; Christian Becker; Andrea Maul-Pavicic; Karin Beutel; Gritta Janka; Gillian Griffiths; Stephan Ehl; Hans Christian Hennies
Journal:  Am J Hum Genet       Date:  2009-10       Impact factor: 11.025

10.  Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin.

Authors:  H Nakajima; H L Park; P A Henkart
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  300 in total

Review 1.  Computational studies of peptide-induced membrane pore formation.

Authors:  Richard Lipkin; Themis Lazaridis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-08-05       Impact factor: 6.237

2.  HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival.

Authors:  Ashwin Ajith; Vera Portik-Dobos; Anh Thu Nguyen-Lefebvre; Christine Callaway; Daniel D Horuzsko; Rajan Kapoor; Carlos Zayas; Katsumi Maenaka; Laura L Mulloy; Anatolij Horuzsko
Journal:  FASEB J       Date:  2019-01-08       Impact factor: 5.191

Review 3.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

4.  Protective vaccination alters gene expression of the liver of Balb/c mice in response to early prepatent blood-stage malaria of Plasmodium chabaudi.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel Azeem S Abdel-Baki; Denis Delic; Frank Wunderlich
Journal:  Parasitol Res       Date:  2018-02-05       Impact factor: 2.289

5.  Interferon-γ induces cancer cell ferroptosis.

Authors:  Laurence Zitvogel; Guido Kroemer
Journal:  Cell Res       Date:  2019-09       Impact factor: 25.617

6.  Regulation of perforin activation and pre-synaptic toxicity through C-terminal glycosylation.

Authors:  Imran G House; Colin M House; Amelia J Brennan; Omer Gilan; Mark A Dawson; James C Whisstock; Ruby Hp Law; Joseph A Trapani; Ilia Voskoboinik
Journal:  EMBO Rep       Date:  2017-08-14       Impact factor: 8.807

7.  A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma.

Authors:  Qunfeng Wu; Liya Pi; Thu Le Trinh; Chaohui Zuo; Man Xia; Yu Jiao; Zhouhua Hou; Sung Jo; William Puszyk; Kien Pham; David R Nelson; Keith Robertson; David Ostrov; Pranela Rameshwar; Chang Qing Xia; Chen Liu
Journal:  Mol Ther       Date:  2017-08-10       Impact factor: 11.454

8.  Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect.

Authors:  Wei Du; Hemn Mohammadpour; Rachel E O'Neill; Sandeep Kumar; Chuan Chen; Michelle Qiu; Lin Mei; Jingxin Qiu; Philip L McCarthy; Kelvin P Lee; Xuefang Cao
Journal:  Oncoimmunology       Date:  2017-11-16       Impact factor: 8.110

Review 9.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

10.  Cold-inducible RNA-binding protein activates splenic T cells during sepsis in a TLR4-dependent manner.

Authors:  Alexandra C Bolognese; Archna Sharma; Weng-Lang Yang; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Cell Mol Immunol       Date:  2016-08-29       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.